Introduction#
Optimi Health Corp. has announced the start of a public offering of its common shares in the United States. This move is part of its strategy to list on the Nasdaq Capital Market.
Details of the Offering#
Joseph Gunnar & Co., LLC is the sole book-running manager for this offering. Optimi has applied to list its shares on Nasdaq under the ticker symbol "OPTH." If approved, the shares will trade on both Nasdaq and the Canadian Securities Exchange, where they are currently listed.
Share Consolidation#
To meet Nasdaq's minimum share price requirement, Optimi's board of directors has approved a 30-to-1 share consolidation. This means that for every 30 shares currently held, shareholders will receive one share after the consolidation. Before this adjustment, the company has 96,776,919 shares outstanding, which will reduce to approximately 3,225,897 shares post-consolidation, not counting fractional shares or proceeds from the offering. Fractional shares will not be issued; instead, they will be rounded down to the nearest whole share.
Regulatory Process#
The public offering will be conducted through a prospectus that is part of a registration statement filed with the Securities and Exchange Commission (SEC). However, this registration statement has not yet become effective. Notably, shares from this offering will not be available to Canadian residents, as specified by the company.
Company Focus#
Optimi Health specializes in the manufacturing and distribution of finished psychedelic drug products. The completion of this offering is contingent upon market conditions and the review processes of both the SEC and Nasdaq.